Roberto Iacovelli
Mar 23, 2025, 09:00
Roberto Iacovelli: The surgical outcomes to neoadjuvant durvalumab in NIAGARA trial for NMIBC
Roberto Iacovelli, Medical oncologist at Gemelli Polyclinic Foundation IRCCS, shared a post on X:
“Prof Catto presented at EAU25 the surgical outcomes to neoadj. durvalumab in NIAGARA trial for NMIBC. No change for type, timiming and complications.”
More posts featuring Roberto Iacovelli.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 23, 2025, 08:34
Mar 23, 2025, 08:20
Mar 23, 2025, 08:05
Mar 23, 2025, 07:57
Mar 23, 2025, 07:36
Mar 23, 2025, 07:25
Mar 23, 2025, 06:59
Mar 23, 2025, 06:47